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N RECENT REVIEWS the progress already I achieved in homotransplantation of the 
liver was summarized [1,2]. In principle, the 
feasibility of such operations has been proved 
since four dogs in our laboratory have lived for 
more than a year and a half after total recipient 
hepatectomy and concomitant orthotopic 
homotransplantation ; chronic survival has also 
been achieved by Moore [3] and Mikaeloff, 
Kestens, and Dureau [4]. Moreover, important 
information has accrued on the alternative 
method of auxiliary hepatic homotransplanta- 
tion, a procedure which does not involve recip- 
ient hepatectomy but which has significant 
physiologic disadvantages [5,6]. Chronic sur- 
vival in man has not been obtained after either 
kind of operation. 
Instead of reviewing this information again, 
an attempt will be made in the following re- 
marks to define some of the broad areas of re- 
search which hopefully will lead to practical 
clinical application of these experimental pro- 
cedures. Reference will be made to certain de- 
velopments in renal transplantation when these 
are directly applicable to homotransplantation 
of other organs. 
The factor which most seriously limits de- 
velopment of this field is the inadequacy of 
present day inlmunosuppressive therapy. Those 
regimens which have made chronic survival 
possible after renal homotransplantation are 
probably no less effective in preventing liver 
homograft rejection; however, there is reason 
to believe that their use may be more hazardous 
largely because of the greater magnitude of the 
surgical undertaking. Thus, pulmonary sepsis, 
which is a common and often fatal early com- 
plication after renal homotransplantation, has 
been observed after virtually every attempt a t  
clinical transplantation of the liver. 
In addition, there may be more specific ob- 
jection to the use of azathioprine and predni- 
sone, the two most important agents currently 
being employed. I t  has been well documented 
in the dog that azathioprine is hepatotoxic [7]. 
The evidence that it causes similar injury to the 
liver in man is more tenuous [ 8 ] ;  nevertheless, 
a growing number of patients have been re- 
ported to have "hepatitis" after otherwise 
successful renal homotransplantation. Steroids 
can also cause injury to the liver. Fatty infiltra- 
tion and even cirrhosis can be produced in ani- 
mals [9-111 or man [12,13] by their protracted 
use in high dosage. The need for better agents 
has been recognized by most workers in this 
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TABLE I 
SURVIVAL OF DOGS TREATED WITH HORSE ANTI-DOG- 
LYMPHOCYTE PLASMA (ALP) OR SERUM (ALS) 
Mean Standard Range 
Group No. Survival Devia- 
(days) tion 
Controls 16 11.3 4.58 5-16 
Dogs with unmodi- 
fied ALP 25 32.3 33.3 4-144 
Dogs with absorbed 
ALS 6 27.2 12.95 13-49 
field and has led to the evaluation of many new 
immunosuppressive technics. 
Perhaps the most promising of these has been 
.the development of antilymphocyte serum 
(ALS) or plasma (ALP). Knowledge that 
heterospecific antisera could destroy lympho- 
cytes and could mitigate various hypersensi- 
tivity reactions preceded their employment for 
prevention of rejection as Woodruff [14], 
Waksman, Arbouys, and Arnason [15], Gray 
et al. [16], and Sacks, Fillipone, and Hume 
[17] have taken pains to point out. Woodruff 
[Id], working with rabbit anti-rat-lymphocyte 
serum, was the first to allude to potentiation of 
homograft survival; he later reported that this 
effect was increased by the addition of recipient 
thoracic duct lymph drainage [18,19]. Jeejee- 
bhoy [20] and Monaco, Wood, and Russell [21] 
simultaneously reported even more striking skin 
homograft protection and showed in addition 
that thymectomy added to the efficacy of the 
therapy. Levey and Medawar [22] and Monaco 
et al. [23] have shown that the second-set re- 
action can be partially prevented, a fact of im- 
portance in considering possible mechanisms of 
action [22]. 
The foregoing skin graft experiments were 
performed either on genetically controlled rat, 
TABLE 11
SURVIVAL OF DOGS TREATED SOLELY WITH HORSE ALP 
AFTER ORTHOTOPIC LIVER TRANSPLANTATION 
Mean Standard Range Group No. Survival Deviation 
(days) (days) 
Controls 22 7 . 1  2.2 2-10 
Dogs with 
ALP 8 15.6* 9 .2  6-33 
* One animal was still alive after three weeks. 
McCardle, and Iwaski 
guinea pig, or mouse strains, employing rabbit 
antiserum. Although there have been no re- 
ports of the use of ALS in outbred larger ani- 
mals, trials with renal homografts are known by 
personal communication to have been carried 
out in dogs by Woodruff (Edinburgh), Calne 
and Medawar (London), Hume (Richmond), 
Monaco (Boston), Murray (Boston), and 
Lawson (Portland) producing the antiserum in 
the rabbit, sheep, cow, and horse. In our lab- 
oratories horse anti-dog-lymphocyte plasma or 
antiserum has been raised by the repeated sub- 
cutaneous inoculation of canine lymphocytes 
obtained from the lymph nodes of multiple 
donors. The response was followed with leuko- 
agglutinin titers which rose from 1 : 4 to 1 : 32 to 
128. The resulting ALP in unmodified form was 
toxic, causing death in eleven of thirty-six dogs 
tested. Anaphylaxis and acute anemia were 
common. Nevertheless, the remaining twenty- 
five animals pretreated with pooled ALP for 
two or three weeks and ultimately subjected to 
renal homotransplantation and bilateral ne- 
phrectomy had significant prolongation of life. 
Postoperatively, one to four ml. per kg. per day 
of antiserum was administered intraperitone- 
ally, daily a t  first and later a t  intervals as long 
as two to four weeks. Mean survival was 32.3 
days. (Table I.) 
Subsequently, specimens from the same 
horses were prepared as antilymphocyte serum 
(ALS) and absorbed with dog red blood cells. 
Removal of most of the heteroagglutinin in 
this way reduced the severity of both the recip- 
ient anemia and the number of anaphylactic 
reactions. Six dogs received renal homografts 
after comparable pretreatment (Table I), with 
a mean survival of 27.2 days (range thirteen to 
forty-nine days). The retention of immuno- 
suppressive effect suggests that the efficacy of 
the material is not dependent upon toxicity, 
an observation also made recently by several 
other investigators. 
Unmodified ALP has been used to treat dogs 
after transplantation of the liver. Although few 
in number, the experiments indicate that pro- 
longation of viability can also be obtained with 
this organ. Eight animals were provided with 
orthotopic homografts after complete extirpa- 
tion of their own liver. Subsequent survival was 
six to thirty-three days (average 15.6 days), a 
significant improvement (p <0.02) over that 
previously est:ablished for the untreated animal 
after such an operation. (Table 11.) Neverthe- 
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FIG. 1. Course of a dog treated solely with antilymphocyte plasma before and after ortho- 
topic liver homotransplantation. Note the sustained lymphopenia after institution of 
therapy. Despite significant prolongation of life, the eventual cause of failure was re- 
jection as reflected in the deteriorating liver chemistries. 
less, the death of each animal was due to rejec- 
tion. (Fig. 1.) 
In the dog, results using ALS or ALP for 
either renal or hepatic homotransplantation 
are inferisor to those which are attainable with 
azathioprine, but the hope of further improve- 
ment is well founded. The aforementioned 
experiments were performed with horse serum 
of very low leukoagglutinin titer. Since then, it 
has been found that titers of 1 : 2,400 or greater 
can easily be produced with proper immuniza- 
tion technics. In addition, Monaco and his 
associates [23] have recently reported that the 
active component of rabbit anti-mouse-lyrnpho- 
cyte serum is fully preserved in purified gamma 
globulin, and Woodruff [24] has further iso- 
lated it in rabbit anti-rat-lymphocyte serum to 
the 7-S fraction. Several laboratories including 
our own are presently isolating more or less 
pure and highly concentrated antibody prep- 
arations for trials, both for the dog and for 
eventual use in man. 
The ultimate role of ALS in the immuno- 
suppressive armamentarium is still speculative. 
Conceivably, it may be used alone; more likely, 
it can be combined with reduced doses of the 
currently available agents. Its unique appeal, 
as Levey and Medawar have pointed out [22], 
is that it is the only highly specific immuno- 
suppressive agent available today. Further- 
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FIG. 2. Survival of sixty-four patients who received renal homografts from living volunteer donors 
between November 1962 and March 1964. No effort a t  prospective white cell antigen matching 
was made with these recipients and their donors. Note the poor results when nonrelated donors 
were used; the loss rate was heavy during the first months and has continued into the second post- 
operative year. The evident biologic unsuitability of randomly selected nonrelated donors is rele- 
vant to liver homotransplantation since all hepatic homografts will have to be procured from 
cadavers. 
more, hepatotoxicity of ALS has not been a single kidney. In contrast (Fig. 2), only four 
observed in any of the investigations to which of the eighteen who received homografts from 
we have alluded. nonrelated volunteers during the same period 
HISTOCOMPATIBILITY 
The desirability of improving immunosup- 
pressive therapy is generally acknowledged. 
An alternative approach which would reduce 
the need for heavy immunosuppression would 
be the perfection of human histocompatibility 
analysis. A small number of either dogs or 
human subjects, receiving homografts from 
randomly selected nonrelated donors and 
were still alive a t  the end of twenty-four months. 
With the use of presently available immunosup- 
pressive measures, the need is urgent in non- 
related cases to find a means of selecting a bio- 
logically suitable donor in advance, and pre- 
sumably this will be advantageous even if im- 
proved immunosuppressive technics are de- 
veloped. 
Unfortunately, the location, number, and na- 
ture of human histocompatibility antigens are 
treated with immunosuppression, have sur- incompletely understood. It is possible that 
prisingly little evidence of subsequent rejection. such information will come from investigations 
A similar small percentage has acute graft of human isoimmune antisera obtained from 
repudiation which-is not preventable with any 
currently available therapy. The majority have 
significant rejection which can, however, be 
more or less favorably modified, but often a t  
the expense of fatal drug toxicity. It is highly 
likely that these divergent results are due 
chiefly to a corresponding spectrum of chance 
host-donor histocompatibility. 
The unacceptability of random pairing par- 
ticularly when nonrelated donors are employed, 
as will be necessary for procurement of liver 
homografts, is well exemplified by the results 
with renal homotransplantation a t  the Uni- 
versity of Colorado Medical Center. (Fig. 2.) 
Of forty-six patients provided with kidneys 
from blood relatives. almost two thirds sur- 
patients who have accidentally or deliberately 
been sensitized to white cell antigens. The ag- 
glutination or cytolysis of test lymphocytes by 
such antisera implies the presence of the same 
or a similar antigen as that which originally 
sensitized the donor, and failure of such a re- 
action implies the absence of the antigen. At 
the Seventh International Transplantation 
Conference, the papers of which are to be pub- 
lished in the December 1966 issue of the Annals 
of the New York Academy of Sciences, evidence 
was reviewed that many of the antisera used in 
Europe by Dausset, Van Rood, and Ceppellini 
were the same as or similar to those used in the 
United States by Terasaki, Payne, Amos, and 
others. The ~ooled information from these 
vived for two years with continuous function of various investigators is being employed for de- 
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ductive genetic studies of the human antigenic 
profile. 
The most significant reservation with this 
type of approach has stemmed from uncer- 
tainty that the antigenic systems being ex- 
amined were related in any way to histocom- 
patibility. The most convincing evidence that 
such a relation does exist derives from the 
studies of Terasaki and his associates 125,261 
who retrospectively studied all cases of renal 
homotransplantation at the University of 
Colorado Medical Center in which survival of 
more than a year had been obtained. Chronic 
survival was shown to be possible with signifi- 
cant donor-recipient antigen mismatches, but 
the best clinical results were in the best matched 
pairs. More complete data were subsequently 
obtained from correlation of two year findings 
on biopsy in these same patients with the 
quality of the Terasaki match. These studies by 
Porter et al. [25,27] indicated a high degree of 
correlation between the state of morphologic 
preservation of the renal homograft and the 
completeness of antigen matching. 
Recently, the Terasaki method has been 
employed for selection of donors [28]. Twenty- 
six patients were treated eleven to eighteen and 
a half months ago, thirteen with familial homo- 
grafts and thirteen with nonrelated kidneys. 
Because of the limited number of potential 
suitable donors within a given family, the 
choice in the related series was not much greater 
than that in the earlier series of nonmatched 
cases previously described herein. In contrast, 
the availability of a large donor pool made 
feasible much greater selectivity for the non- 
related recipients than had previously been 
possible. The early results in these prospectively 
typed cases are summarized in Figure 3. It will 
be noted that after eleven months the survival 
in the nonrelated and related groups was 
exactly the same. No deaths have occurred in 
either group after eleven months. 
These studies support the hope that typing 
for histocompatibility can become a useful 
clinical tool. As imperfect as the matching 
technics now are, there is reason to believe 
that they may provide a simple and practical 
means of donor screening in the relatively near 
future. 
TEMPORARY HEPATIC SUPPORT 
An important element in the development of 
renal homotransplantation has been the avail- 
0 0  
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FIG. 3. Results of renal transplantation in patients 
whose donors were selected by Terasaki's antigen 
matching method. Note that survival after eleven 
months was exactly the same in both the related and 
nonrelated cases. Compare these results with those in 
Figure 2. 
ability of high quality renal dialysis. These sup- 
porting technics have permitted pretransplant 
resuscitation of critically ill patients who could 
not otherwise have been subjected to operation. 
Furthermore, interim support is not infre- 
quently required after transplantation either 
because prompt early excretion is not obtained 
or because of subsequent temporary failure of 
the homograft due to reversible rejection. 
Comparable procedures are not now available 
for patients with hepatic insufficiency. The 
develovment of an artificial liver in the im- 
mediate future appears unlikely due to the 
complex and incompletely understood function 
of this organ. 
The brilliant investigations of Eiseman, 
Liem, and Raffucci [29], extended by Norman 
et al. [30] and other investigators [31,32], have 
explored the alternative possibility of utilizing 
extracorporeal pig or calf livers temporarily re- 
vascularized in parallel with the recipient's own 
circulation.   he principal disadvantages of this 
approach are the short-term benefit' which can 
be expected and the relatively complicated in- 
strumentation which is required. 
A further application of this concept has re- 
cently been tested in our laboratory. Total hep- 
atectomy was performed on six dogs under 
pentobarbital anesthesia. From five to seven 
hours later an extracorporeal liver from a non- 
related mongrel donor was transplanted to the 
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FIG. 4. Technic of extracorporeal liver transplantation 
in the dog. The portal vein is ligated and the hepatic 
artery anastomosed to the carotid artery. Hepatic 
venous outflow through the infrarenal inferior vena 
cava of the graft is channeled into the recipient external 
jugular vein. 
neck of the anhepatic animal. The extracor- 
poreal liver was provided only with an arterial 
supply. (Fig. 4.) The venous outflow was 
through the infrarenal inferior vena cava, the 
suprahepatic vena cava being closed with su- 
tures. The liver was supported in position with 
moist gauze sponges. 
The survival in the six consecutive experi- 
ments is shown in Table 111. Total mean survi- 
TABLE 111 
SURVIVAL I N  SIX DOGS SUBJECTED TO PRELIMINARY 
HEPATECTOMY AND SUBSEQUENTLY PROVIDED WITH AN 
EXTRACORPOREAL CERVICAL HEPATIC HOMOGRAFT 
Time (hr.) Total 
from Hepa- (hr.) after Survival (hr.) Data tectomy Hepatic 
after 
to Hepatic Support Hepatectomy Support 
Mean 6.2 23.8 30.3 
Standard 
deviation 0.75 7.0 7.74 
Range 5-7 13-31 18-38 
TABLE IV 
VOLUME AND BILIRUBIN CONTENT OF BILE COLLECTED 
FROM FIVE CERVICAL LIVER HOMOGRAFTS 
Data Time in Hours 0-6 7-12 13-18 19-24 25-30 
Volume bile (cc.) 
Number 5 5 4 3 2 
Mean 19.7 25.6 10.4 6.6 2.2 
Standard 
deviation 6.6 24.8 4.5 3.6 2.8 
Total bilirubin 
(mg.%) 
Number 5 5 4 3 ... 
Mean 137 187 237 245 . . . 
Standard 
deviation 84 112 128 58 ... 
Direct bilirubin 
(mg.%) 
Number 5 5 4 3 
Mean 91 87 109 94 ... 
Standard 
deviation 59 16 66 23 . . . 
val after initial hepatectomy was 30.3 hours; 
average survival after the extracorporeal trans- 
plant was 23.8 hours. In contrast to anhepatic 
animals under barbitrate anesthesia these dogs 
awakened promptly and required repeated re- 
anesthetization. 
Bile production was observed promptly and 
\ 
FIG. 5. Technic of extracorporeal liver homotransplanta- 
tion used in case I. The superficial femoral artery was 
anastomosed to the hepatic artery, and the hepatic 
venous outflow was directed into the femoral system. 
The liver was left i n  situ for three and a half days. 
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FIG. 6. Course of a seventeen year old boy dying of hepatitis who was provided with an extracorporeal liver homo- 
graft. There was prompt clearing of bilirubinemia and alkaline phosphatemia but little evidence of synthetic func- 
tion. 
continued for thirteen to  thirty hours after re- 
vascularization. Bile flow was measured in five 
of the six dogs, and the average value for six 
hour periods as well as the bilirubin concentra- 
tions are summarized in Table IV. A sharp dim- 
inution in volume was usually observed after 
fifteen or sixteen hours. 
Sections of the extracorporeal livers were 
examined a t  autopsy by Dr. Richard A. Mac- 
Donald. There was no evidence of rejection. 
The most prominent feature was sinusoidal 
congestion, often with atrophy and/or centri- 
lobular necrosis of hepatocytes. I n  two instances 
the degree of congestion was extremely severe. 
The demonstration that  moderately pro- 
longed hepatic support was possible without 
the need for special equipment prompted the 
use of this method for two patients dying of 
hepatitis. 
CASE I. A sixteen year old white boy was admitted 
September 27, 1965 with coma and jaundice. Three 
weeks previously he was hospitalized elsewhere with 
infectious hepatitis which at first responded favora- 
bly to bedrest and diet but which subsequently be- 
came worse. One day prior to admission to Colorado 
General Hospital coma developed and he became 
deeply jaundiced. 
Numerous petechiae were present over the entire 
body. The liver was felt two fingerbreadths below 
the right costal margin. There was bilateral sus- 
tained ankle clonus and generalized hyper-reflexia. 
Bilirubin, alkaline phosphatase, and prothrombin 
time are depicted in Figure 6. Serum glutamic oxala- 
cetic transaminase was 1,700 Sigma-Frankel units. 
Blood type was A positive. He was treated with 
intravenous glucose, intragastric neomycin, enemas, 
hydrocortisone, arginine, vitamin K, and multiple 
vitamins. His neurologic status deteriorated with the 
development of decerebrate rigidity and bilateral 
Babinski reflexes. 
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FIG. 7. Technic for extracorporeal transplantation of a 
chimpanzee heterograft (case 11). The details are simi- 
lar to those in case I except that the femoral vein was 
transected and the distal end anastornosed to the 
portal vein. 
Twenty-four hours after admission an extracor- 
poreal liver was placed in the right groin; anesthesia 
was unnecessary. The donor was a sixty-nine year 
old man who died of myocardial infarction in an 
adjacent hospital. External cardiac massage was 
conducted for forty minutes after death at  the end of 
which time the liver was perfused with chilled lac- 
tated Ringer's solution and excised. The time from 
death to re-establishment of a blood supply was 155 
minutes. Only the hepatic artery was revascularized. 
(Fig. 5 . )  A cross leg cast was applied to damp con- 
vulsive movement of the legs. Bile production was 
noted within minutes after re-establishment of the 
blood supply. 
The biochemical changes after the procedure are 
depicted in Figure 6. A sharp drop in the serum 
bilirubin content and alkaline phosphatase occurred 
promptly. The slight improvement in prothrombin 
time was of doubtful significance. Administration of 
albumin made impossible the evaluation of changes 
in the serum protein. Due to leakage in the ductal 
system, accurate collection of bile was impossible. 
Several observers thought there was lessening of 
the comatose state, but this could not be objectively 
documented. Nine and a half hours postoperatively 
he had a generalized convulsion with respiratory 
arrest and thereafter had to be maintained on a 
respirator. His subsequent course was one of progres- 
sive deterioration with the development of fixed, 
dilated pupils, intermittent bleeding from the gastro- 
intestinal tract and oropharynx, and renal shutdown. 
His temperature was maintained at  approximately 
37"~.  with a hypothermic blanket. He died eighty- 
four hours after operation. The liver retained a good 
color and turgor throughout. 
Biopsies of the donor liver were obtained at  one, 
forty-two, and sixty-six hours as well as at  autopsy 
and were examined by Dr. K. A. Porter of London, 
England. The first specimen was normal except for 
some fatty infiltration of centrilobular hepatocytes. 
Subsequently progressive loss of centrilobular hepa- 
tocytes was noted until a t  autopsy only a few hepato- 
cytes immediately adjacent to the portal veins re- 
mained alive. By this time there was moderate infil- 
tration of the portal tracts with lymphoid cells, less 
than 5 per cent of which were pyroninophilic. The 
patient's own liver was virtually destroyed by hepa- 
titis, with only a few residual hepatocytes. 
CASE 11. A seven year old girl was admitted to 
Colorado General Hospital on October 11, 1965 in 
hepatic coma. In June she had had acute viral 
hepatitis with subsequent incomplete clearing of the 
icterus. Three weeks prior to the present admission, 
the jaundice deepened, with rapidly developing as- 
cites a few days later. Two days before admission 
she became comatose. 
Petechiae were widespread. The liver and spleen 
could not be felt. Results of chemistries were: blood 
urea nitrogen 6 mg. per cent, bilirubin 18.8 mg. per 
cent, blood sugar 100 mg. per cent, ammonia 227 
pg. per cent, alkaline phosphatase 12.4 Bessey- 
Lowry units, and prothrombin time 20 per cent. 
Plasma phenylalanine, tyrosine, and methionine 
were elevated. Blood type was 0 positive. She was 
treated with intravenous Swiss gamma globulin, in- 
tramuscular gamma globulin, intravenous glucose, 
oral and rectal neomycin, hydrocortisone, vitamin 
K and, multivitamins. Efforts to find a suitable 
cadaveric liver for extracorporeal transplant were 
unsuccessful. 
Consequently, a chimpanzee liver heterograft was 
attached to the right femoral vessels twenty-four 
hours after admission. The chimpanzee, which had 
blood type 0, weighed 40 pounds. The animal was 
cooled to 30°c. before operation. The liver was 
washed free of blood by perfusion of lactated 
Ringer's solution through the portal vein. The is- 
chemic interval was sixty minutes. The technic of 
anastomosis (Fig. 7) differed from that in case I in 
that the portal vein was provided with a venous in- 
flow from the distal transected femoral vein, thereby 
establishing a double blood supply. 
For the first twelve hours the color and consist- 
ency of the liver were relatively normal. Portions of 
the right lobe then became turgid and discolored, a 
process which gradually involved most of the liver. 
The heterograft was removed twenty-five hours after 
revascularization. During this interval the serum 
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bilirubin dropped from 18.8 to 9 mg. per cent and the 
alkaline phosphatase from 12.4 to 8.4 Bessey-Lowry 
units. On the day after removal of the graft, the 
bilirubin had risen back to 22.8 mg. per cent. There 
was no improvement in prothrombin time. 
During the period of extracorporeal hepatic sup- 
port the coma lightened to an irritable and irrational 
state. In the ensuing week her neurologic condition 
was variable, but at the end of this time she had a 
remarkable clearing of sensorium which lasted for a 
few days despite no improvement in the liver 
chemistries. Several days later gastrointestinal 
hemorrhage and increasing hepatic failure developed 
leading to death sixteen days after admission. At 
autopsy she had postnecrotic cirrhosis with evidence 
of active hepatitis. Multiple ulcerations of the esoph- 
agus, stomach, and duodenum as well as diffuse 
lntracerebral hemorrhage were present. 
The chimpanzee heterograft was biopsied at one 
hour, twelve hours, and at the time of its removal. 
The tissues were examined by Dr. K. A. Porter. The 
first specimen was essentially normal. By twelve 
hours tiny fat droplets had accumulated in the 
hepatocytes. At removal several nonviable areas 
were located superficially, but the central portion of 
the liver was well preserved. Antemortem clot was 
present in a number of small vessels, and the main 
hepatic artery was completely occluded. Many 
normal hepatocytes were found, particularly around 
the periphery of the lobules. The portal tracts were 
lightly infiltrated with mononuclear cells, few of 
which had pyronine-positive cytoplasm. 
Comment: The clinical benefit in these two 
cases was disappointing. In  each case sub- 
stantial clearance of bilirubin and alkaline 
phosphatase seemed to have occurred, but 
there was little or no evidence of synthetic 
activity despite the fact that the grafts were in 
place for one to  three and a half days. In  
case 11 there appeared to be a chance for chronic 
survival, but progression of the patient's origi- 
nal disease ultimately led to  death. In  view of 
these experiences and those obtained by others 
with the porcine liver, i t  seems unlikely that 
these temporizing technics will play an im- 
portant role in promoting the feasibility of 
liver transplantation. 
SUMMARY 
Three general areas of research which bear on 
the developing field of liver transplantation are 
reviewed. These are: (1) the prospects of ob- 
taining better immunosuppression with partic- 
ular reference to  heterologous antilymphocyte 
serum; (2) the possible use of antigen matching 
technics as an advanced indicator of donor- 
recipient histocompatibility; (3) a simplified 
system of extracorporeal transplantation de- 
signed to  provide temporary hepatic support. 
ADDENDUM 
The dog still alive three weeks after ortho- 
topic liver transplantation a t  the time the 
manuscript was submitted has continued to do 
well and is now two and a half months post- 
operative. He has not received any ALS after 
three weeks. Another dog, pretreated with ALS, 
has now lived for six weeks after orthotopic 
transplantation; this animal has never received 
postoperative therapy. Both dogs now have 
marked lymphocytosis. The effect of ALS is 
therefore relatively long-lasting and does not 
require continuous lymphopenia. 
In  addition, orthotopic liver transplantation 
has subsequently been performed in four dogs 
being treated solely with concentrated gamma 
globulin purified from horse ALS. Three of the 
four dogs are in their fourth postoperative 
week. The evidence is thus mounting that 
ALS products may eventually find a practical 
place in immunosuppressive regimens in man. 
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